The Obesity Medicine Association (OMA) will host its annual conference, Obesity Medicine 2025, from April 23-27, 2025, in National Harbor, Maryland. As the largest organization dedicated to healthcare professionals—including physicians, nurse practitioners, physician assistants, and others—who are committed to improving the health and lives of patients impacted by obesity, OMA provides a platform for education and networking. This conference will bring together experts in obesity medicine to share knowledge and foster community among those working in the field.

To secure your attendance at this event, we highly recommend registering promptly by clicking this link. By doing so, you will have the chance to secure accommodations, access travel information, plan your itinerary, and guarantee your participation in educational and networking activities before they reach full capacity.

Below, you will find a list of sessions focused on anti-obesity medications, specifically GLP-1 agonists that we are eagerly looking forward to at #ObesityMedicine2025. The sessions are organized in chronological order for your convenience.

Medication

  • Date: Wednesday, April 23, 2025
  • Time: 2:50 PM – 4:20 PM East Coast USA Time
  • Location: Potomac AB
    • Description: This session will focus on the role of medications in obesity management. Participants will learn how to incorporate anti-obesity medications (AOMs) into treatment plans, how to assess and document a patient’s medication and supplement history, and how to tailor interventions for specific populations affected by obesity. The session will also cover long-term management strategies for maintaining the obesity treatment plan.

Treatment Strategies 2

  • Date: Thursday, April 24, 2025
  • Time: 11:30 AM – 12:30 PM East Coast USA Time
  • Location: Potomac AB
    • Description: In this session, attendees will explore the benefits of a multidisciplinary approach to effective weight management. The focus will be on creating personalized treatment strategies for patients with obesity, addressing common challenges such as weight plateaus and regaining lost weight. Attendees will also delve into patient care issues like stigma, bias, and communication, as well as ethical considerations in treatment. The session will highlight the importance of advocacy, teamwork, and public health efforts to combat obesity.

Dietary Interventions for Obesity with and without GLP-1s

  • Date: Friday, April 25, 2025
  • Time: 11:35 AM – 12:35 PM East Coast USA Time
  • Location: Potomac AB
    • Description: This session will explore how dietary interventions can complement obesity treatment, focusing on culturally sensitive, patient-centered approaches. With the advent of effective GLP-1 medications, many patients are successfully managing their weight, but not everyone has access or tolerance for these drugs. The session will emphasize strategies that go beyond traditional "eat less" advice, promoting nutrient-dense foods that support satiety and metabolic health. For patients on GLP-1s, the goal is to maintain nutrient intake while minimizing muscle loss. The session will provide clinicians with practical, evidence-based dietary advice for patients both on and off GLP-1 medications.

Evidence-Based Management of MASLD and MASH in Patients with Obesity

  • Date: Friday, April 25, 2025
  • Time: 1:50 PM – 2:35 PM East Coast USA Time
  • Location: Potomac AB
    • Description: Up to 90% of individuals with obesity are affected by Metabolic Associated Steatotic Liver Disease (MASLD), and a significant number are at risk of progressing to Metabolic Associated Steatohepatitis (MASH) and liver fibrosis. This session will provide practical strategies for early diagnosis and risk assessment, using non-invasive diagnostic tools. Evidence-based lifestyle interventions, including dietary changes and physical activity, will be highlighted for their role in reversing MASLD and improving MASH. Participants will also explore the impact of weight loss, especially a ≥10% reduction, and review emerging pharmacological treatments such as GLP-1 receptor agonists, SGLT2 inhibitors, and resmetirom.

Anti-Obesity Medications in Complex Cases

  • Date: Saturday, April 26, 2025
  • Time: 9:00 AM – 10:00 AM East Coast USA Time
  • Location: Potomac AB
    • Description: This session will delve into the application of anti-obesity medications through complex, case-based discussions. Attendees will learn to navigate challenges such as comorbidities, contraindications, and treatment resistance. Emphasizing evidence-based approaches, the session will offer strategies for personalizing obesity treatment plans and managing the side effects of obesity medications. Participants will gain insights into how to assess the risks and benefits of various treatments in these intricate cases.

The #OM2025 is set to be an enriching and informative event. We recommend clicking here to explore the comprehensive list of topics and sessions that will be covered at this significant event. Don’t miss the opportunity to expand your expertise — register today.

Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.

Copyright © 2025 Guideline Central, All Rights Reserved.